# BCG Immunotherapeutic

## OncoTICE 2-8×10^8 CFU (專案進口)

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-----------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | IONC5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 適應症     | Bladder cancer, Stage Ta and/or T1 papillary tumors following transurethral resection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 用法用量   | TICE BCG: One dose instilled into the bladder (retain for 2 hours) once weekly for 6 weeks (may repeat cycle 1 time) followed by approximately once monthly for at least 6-12 months. Have patient avoid fluid intake for 4 hours prior to treatment and empty bladder prior to instillation. Slowly instill via catheter into the bladder by gravity flow; do not force by depressing plunger. Retain suspension for up to 2 hours, repositioning the patient every 15 minutes from left side to right side, and supine to prone. After 2 hours, have patient void in a seated position. Have patient increase fluid intake to flush bladder; dispose of all urine voided for 6 hours after instillation with an equal volume of household bleach (this should be done for the first 6 hours after therapy). After administration, patients should drink plenty of water in order to flush the bladder. |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 禁忌       | 1. immunocompromised status including HIV infection (percutaneous and intravesical) 2. urinary tract infection or hematuria (intravesical) 3.acute febrile illness (intravesical) 4. 7 to 14 days following biopsy, transurethral resection, or traumatic catheterization; increased risk for systemic BCG infection (intravesical) 5. active tuberculosis (intravesical) 6. hypersensitivity to BCG products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 副作用     | Hematuria, urinary frequency, dysuria, bacterial UTI. Local irritative symptoms, fever, prostatitis, ureteral obstruction, systemic BCG infection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 孕期建議   | Uknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 哺乳期建議 | Unknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

